Skip to main content
Top
Published in: BioPsychoSocial Medicine 1/2013

Open Access 01-12-2013 | Research

A clinical study of the efficacy of a single session of individual exercise for depressive patients, assessed by the change in saliva free cortisol level

Authors: Megumi Ida, Itsurou Ida, Naoki Wada, Makoto Sohmiya, Masayuki Tazawa, Kenji Shirakura

Published in: BioPsychoSocial Medicine | Issue 1/2013

Login to get access

Abstract

Background

The efficacy of physical exercise as an augmentation to pharmacotherapy with antidepressants for depressive patients has been documented. However, to clarify the effectiveness of exercise in the treatment of depression, it is necessary to distinguish the effect of the exercise itself from the effect of group dynamics. Furthermore, an objective measurement for estimation of the effect is needed. Previous reports adopted a series of group exercises as the exercise intervention and mainly psychometric instruments for the measurement of effectiveness. Therefore, this clinical study was done to examine the effectiveness of a single session of individual exercise on depressive symptoms by assessing the change in saliva free cortisol level, which reflects hypothalamic-pituitary-adrenocortical axis function that is disturbed in depressive patients.

Method

Eighteen medicated patients, who met the DSM-IV-TR criteria for major depressive disorder, were examined for the change in saliva free cortisol levels and the change in subjective depressive symptoms before and after pedaling a bicycle ergometer for fifteen minutes. Within a month after the exercise session, participants conducted a non-exercise control session, which was sitting quietly at the same time of day as the exercise session.

Results

Depressed patients who participated in this study were in remission or in mild depressive state. However, they suffered chronic depression and had disturbed quality of life. The saliva free cortisol level and subjective depressive symptoms significantly decreased after the exercise session. Moreover, the changes in these variables were significantly, positively correlated. On the other hand, although the subjective depressive symptoms improved in the control session, the saliva free cortisol level did not change.

Conclusion

For the first time in depressive patients, we were able to show a decrease in the saliva free cortisol level due to physical exercise, accompanied by the improvement of subjective depressive symptoms. This identified a possible influence of exercise on the hypothalamic-pituitary-adrenal axis in depression.
These results suggest the utility of assessing the effect of physical exercise by saliva free cortisol level in depressive patients who suffer from bio-psycho-social disability.
Appendix
Available only for authorised users
Literature
3.
go back to reference Kennard BD, Silva SG, Tonev S, Rohde P, Hughes JL, Vltiello B, Kratochvil CJ, Curry JF, Emslie GJ, Reinecke M, March J: Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry. 2009, 48: 186-195. 10.1097/CHI.0b013e31819176f9.PubMedCentralCrossRefPubMed Kennard BD, Silva SG, Tonev S, Rohde P, Hughes JL, Vltiello B, Kratochvil CJ, Curry JF, Emslie GJ, Reinecke M, March J: Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry. 2009, 48: 186-195. 10.1097/CHI.0b013e31819176f9.PubMedCentralCrossRefPubMed
5.
go back to reference Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RMA, Shea T: Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 1992, 49: 809-816. 10.1001/archpsyc.1992.01820100053010.CrossRefPubMed Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RMA, Shea T: Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 1992, 49: 809-816. 10.1001/archpsyc.1992.01820100053010.CrossRefPubMed
6.
go back to reference Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, Endicott J, Coryell W, Kunovac JL, Muller TI, Rice JP, Leller MB: Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry. 2000, 57: 375-380. 10.1001/archpsyc.57.4.375.CrossRefPubMed Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, Endicott J, Coryell W, Kunovac JL, Muller TI, Rice JP, Leller MB: Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry. 2000, 57: 375-380. 10.1001/archpsyc.57.4.375.CrossRefPubMed
7.
go back to reference ten Doesschate MC, Koeter MW, Bockting CL, Schene AH, DELTA Study Group: Health related quality of life in recurrent depression: a comparison with a general population sample. J Affect Disord. 2010, 120: 126-132. 10.1016/j.jad.2009.04.026.CrossRefPubMed ten Doesschate MC, Koeter MW, Bockting CL, Schene AH, DELTA Study Group: Health related quality of life in recurrent depression: a comparison with a general population sample. J Affect Disord. 2010, 120: 126-132. 10.1016/j.jad.2009.04.026.CrossRefPubMed
9.
go back to reference Morgan WP: Physical Activity and Mental Health. 1997, Washington. DC: Taylor & Francis Morgan WP: Physical Activity and Mental Health. 1997, Washington. DC: Taylor & Francis
10.
go back to reference Paffenbarger RS, Lee IM, Leung R: Physical activity and personal characteristics associated with depression and suicide in American college men. Acta Psychiatr Scand. 1994, 377: 16-22.CrossRef Paffenbarger RS, Lee IM, Leung R: Physical activity and personal characteristics associated with depression and suicide in American college men. Acta Psychiatr Scand. 1994, 377: 16-22.CrossRef
11.
go back to reference Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, Waugh R, Napolitano MA, Forman LM, Appelbaum M, Doraiswamy PM, Krishnan KR: Effects of exercise training on older patients with major depression. Arch Intern Med. 1999, 159: 2349-2356.CrossRefPubMed Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, Waugh R, Napolitano MA, Forman LM, Appelbaum M, Doraiswamy PM, Krishnan KR: Effects of exercise training on older patients with major depression. Arch Intern Med. 1999, 159: 2349-2356.CrossRefPubMed
12.
go back to reference Mather AS, Rodriguez C, Guthrie MF, McHarg AM, Reid IC, Marion ET, McMurdo MT: Effects of exercise on depressive symptoms in older adults with poorly responsive depressive disorder. Br J Psychiatry. 2002, 180: 411-415. 10.1192/bjp.180.5.411.CrossRefPubMed Mather AS, Rodriguez C, Guthrie MF, McHarg AM, Reid IC, Marion ET, McMurdo MT: Effects of exercise on depressive symptoms in older adults with poorly responsive depressive disorder. Br J Psychiatry. 2002, 180: 411-415. 10.1192/bjp.180.5.411.CrossRefPubMed
13.
go back to reference Blumenthal JA, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, Barbour KA, Herman S, Craighead WE, Brosse AL, Waugh R, Hinderliter A, Sherwood A: Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007, 69: 587-596. 10.1097/PSY.0b013e318148c19a.PubMedCentralCrossRefPubMed Blumenthal JA, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, Barbour KA, Herman S, Craighead WE, Brosse AL, Waugh R, Hinderliter A, Sherwood A: Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007, 69: 587-596. 10.1097/PSY.0b013e318148c19a.PubMedCentralCrossRefPubMed
15.
go back to reference Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS: Cortisol secretion in endogenous depression. I. Basal plasma levels. Arch Gen Psychiatry. 1985, 42: 904-908. 10.1001/archpsyc.1985.01790320076010.CrossRefPubMed Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS: Cortisol secretion in endogenous depression. I. Basal plasma levels. Arch Gen Psychiatry. 1985, 42: 904-908. 10.1001/archpsyc.1985.01790320076010.CrossRefPubMed
16.
go back to reference Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E: Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups: a multicenter study. Arch Gen Psychiatry. 1984, 41: 257-267. 10.1001/archpsyc.1984.01790140047006.CrossRefPubMed Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E: Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups: a multicenter study. Arch Gen Psychiatry. 1984, 41: 257-267. 10.1001/archpsyc.1984.01790140047006.CrossRefPubMed
17.
go back to reference Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK: Serial assessment of corticotoropin-releasing hormone response after dexamethasone in depression: implications for pathophysiology of DST nonsuppression. Biol Psychiatry. 1987, 22: 228-234. 10.1016/0006-3223(87)90237-X.CrossRefPubMed Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK: Serial assessment of corticotoropin-releasing hormone response after dexamethasone in depression: implications for pathophysiology of DST nonsuppression. Biol Psychiatry. 1987, 22: 228-234. 10.1016/0006-3223(87)90237-X.CrossRefPubMed
18.
go back to reference Holsboer F, Lauer CJ, Schreiber W, Krieg JC: Altered hypothalamic-pituitary-adrenocortical regulation in health subjects at high familial risk for affective disorders. Neuroendocrinology. 1995, 62: 340-347. 10.1159/000127023.CrossRefPubMed Holsboer F, Lauer CJ, Schreiber W, Krieg JC: Altered hypothalamic-pituitary-adrenocortical regulation in health subjects at high familial risk for affective disorders. Neuroendocrinology. 1995, 62: 340-347. 10.1159/000127023.CrossRefPubMed
19.
go back to reference Kirschbaum C, Hellhammer DH: Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology. 1994, 19: 313-333. 10.1016/0306-4530(94)90013-2.CrossRefPubMed Kirschbaum C, Hellhammer DH: Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology. 1994, 19: 313-333. 10.1016/0306-4530(94)90013-2.CrossRefPubMed
20.
go back to reference First MB, Frances A, Pincus HA: DSM-IV-TR® Handbook of Differential Diagnosis. 2002, Arlington: American Psychiatric PublishingCrossRef First MB, Frances A, Pincus HA: DSM-IV-TR® Handbook of Differential Diagnosis. 2002, Arlington: American Psychiatric PublishingCrossRef
21.
go back to reference Borg G: Perceived exertion as an indicator of somatic stress. Scand J Rehab Med. 1970, 2: 92-98. Borg G: Perceived exertion as an indicator of somatic stress. Scand J Rehab Med. 1970, 2: 92-98.
23.
go back to reference Ware JE, Kosinski M, Keller SD: SF-36 Physical and Mental Health Summary Scales: A User’s Manual. 1994, Boston: Nimrod: The Health Data Institute of New England Medical Center Ware JE, Kosinski M, Keller SD: SF-36 Physical and Mental Health Summary Scales: A User’s Manual. 1994, Boston: Nimrod: The Health Data Institute of New England Medical Center
24.
go back to reference Beusterien KM, Steinwald B, Ware JE: Usefulness of the SF-36 Health Survey in measuring health outcomes in the depressed elderly. J Geriatr Psychiatry Neurol. 1996, 9: 5-37.CrossRef Beusterien KM, Steinwald B, Ware JE: Usefulness of the SF-36 Health Survey in measuring health outcomes in the depressed elderly. J Geriatr Psychiatry Neurol. 1996, 9: 5-37.CrossRef
25.
go back to reference Buist-Bouwman MA, De Graaf R, Vollebergh WA, Alonso J, Bruffaerts R, Ormel J, ESEMeD/MHEDEA 2000 Investigators: Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six european countries. Acta Psychiatr Scand. 2006, 113: 429-500.CrossRef Buist-Bouwman MA, De Graaf R, Vollebergh WA, Alonso J, Bruffaerts R, Ormel J, ESEMeD/MHEDEA 2000 Investigators: Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six european countries. Acta Psychiatr Scand. 2006, 113: 429-500.CrossRef
26.
go back to reference Buist-Bouwman MA, Ormel J, de Graaf R, de Jonge P, van Sonderen E, Alonso J, Bruffaerts R, Vollebergh WA, ESEMeD/MHEDEA 2000 investigators: Mediators of the association between depression and role functioning. Acta Psychiatr Scand. 2008, 118: 451-458. 10.1111/j.1600-0447.2008.01285.x.PubMedCentralCrossRefPubMed Buist-Bouwman MA, Ormel J, de Graaf R, de Jonge P, van Sonderen E, Alonso J, Bruffaerts R, Vollebergh WA, ESEMeD/MHEDEA 2000 investigators: Mediators of the association between depression and role functioning. Acta Psychiatr Scand. 2008, 118: 451-458. 10.1111/j.1600-0447.2008.01285.x.PubMedCentralCrossRefPubMed
27.
go back to reference Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K: Translation, adaptation, and validation of the SF-36v2TM Health Survey for use in Japan. J Clin Epidemiology. 1998, 51: 1037-1044. 10.1016/S0895-4356(98)00095-X.CrossRef Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K: Translation, adaptation, and validation of the SF-36v2TM Health Survey for use in Japan. J Clin Epidemiology. 1998, 51: 1037-1044. 10.1016/S0895-4356(98)00095-X.CrossRef
28.
go back to reference Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B: Psychometric and clinical tests of validity of the Japanese SF-36v2TM Health Survey. J Clin Epidemiology. 1998, 51: 1045-1053. 10.1016/S0895-4356(98)00096-1.CrossRef Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B: Psychometric and clinical tests of validity of the Japanese SF-36v2TM Health Survey. J Clin Epidemiology. 1998, 51: 1045-1053. 10.1016/S0895-4356(98)00096-1.CrossRef
29.
go back to reference Fukuhara S, Suzukamo Y: SF-36v2 Japanese version. 2004, Kyoto: Institute for Health Outcome and Process Evaluation Research Fukuhara S, Suzukamo Y: SF-36v2 Japanese version. 2004, Kyoto: Institute for Health Outcome and Process Evaluation Research
31.
go back to reference Lam RW, Filteau MJ, Milev R: Clinical effectiveness: the importance of psychosocial functioning outcomes. J Affect Disord. 2011, 132 (Suppl 1): S9-S13.CrossRefPubMed Lam RW, Filteau MJ, Milev R: Clinical effectiveness: the importance of psychosocial functioning outcomes. J Affect Disord. 2011, 132 (Suppl 1): S9-S13.CrossRefPubMed
32.
go back to reference Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M: Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry. 2004, 26: 13-17. 10.1016/j.genhosppsych.2003.07.004.CrossRefPubMed Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M: Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry. 2004, 26: 13-17. 10.1016/j.genhosppsych.2003.07.004.CrossRefPubMed
33.
go back to reference Saarni AI, Suvisaari J, Sintonen H, Pirkola S, Koskinen S, Aromaa A, Lönnqvist J: Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry. 2007, 190: 326-332. 10.1192/bjp.bp.106.025106.CrossRefPubMed Saarni AI, Suvisaari J, Sintonen H, Pirkola S, Koskinen S, Aromaa A, Lönnqvist J: Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry. 2007, 190: 326-332. 10.1192/bjp.bp.106.025106.CrossRefPubMed
34.
go back to reference Keeley RD, Smith JL, Nutting PA, Dickinson LM, Dickinson WP, Kathryn M, Rost KM: Does a depression intervention result in improved outcomes for patients presenting with physical symptoms?. J Gen Intern Med. 2004, 19: 615-623. 10.1111/j.1525-1497.2004.30611.x.PubMedCentralCrossRefPubMed Keeley RD, Smith JL, Nutting PA, Dickinson LM, Dickinson WP, Kathryn M, Rost KM: Does a depression intervention result in improved outcomes for patients presenting with physical symptoms?. J Gen Intern Med. 2004, 19: 615-623. 10.1111/j.1525-1497.2004.30611.x.PubMedCentralCrossRefPubMed
35.
go back to reference Kiive E, Maaroos J, Shlik J, Tõru I, Harro J: Growth hormone, cortisol and prolactin responses to physical exercise: higher prolactin response in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2004, 28: 1007-1013. 10.1016/j.pnpbp.2004.05.035.CrossRefPubMed Kiive E, Maaroos J, Shlik J, Tõru I, Harro J: Growth hormone, cortisol and prolactin responses to physical exercise: higher prolactin response in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2004, 28: 1007-1013. 10.1016/j.pnpbp.2004.05.035.CrossRefPubMed
36.
go back to reference Krogh J, Nordentoft M, Mohammad-Nezhad M, Westrin A: Growth hormone, prolactin and cortisol response to exercise in patients with depression. J Affect Disord. 2010, 125: 189-197. 10.1016/j.jad.2010.01.009.CrossRefPubMed Krogh J, Nordentoft M, Mohammad-Nezhad M, Westrin A: Growth hormone, prolactin and cortisol response to exercise in patients with depression. J Affect Disord. 2010, 125: 189-197. 10.1016/j.jad.2010.01.009.CrossRefPubMed
37.
go back to reference Deuschle M, Hamann B, Meichel C, Krumm B, Lederbogen F, Kniest A, Colla M, Heuser I: Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations. J Clin Psychopharmacol. 2003, 23: 201-205. 10.1097/00004714-200304000-00014.CrossRefPubMed Deuschle M, Hamann B, Meichel C, Krumm B, Lederbogen F, Kniest A, Colla M, Heuser I: Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations. J Clin Psychopharmacol. 2003, 23: 201-205. 10.1097/00004714-200304000-00014.CrossRefPubMed
38.
go back to reference Hinkelmann K, Moritz S, Botzenhardt J, Muhtz C, Wiedemann K, Kellner M, Otte C: Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: a longitudinal study. Psychoneuroendocrinology. 2012, 37: 685-692. 10.1016/j.psyneuen.2011.08.012.CrossRefPubMed Hinkelmann K, Moritz S, Botzenhardt J, Muhtz C, Wiedemann K, Kellner M, Otte C: Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: a longitudinal study. Psychoneuroendocrinology. 2012, 37: 685-692. 10.1016/j.psyneuen.2011.08.012.CrossRefPubMed
39.
go back to reference Scharnholz B, Weber-Hamann B, Lederbogen F, Schilling C, Gilles M, Onken V, Frankhauser P, Kopf D, Deuschle M: Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial. Psychiatry Res. 2010, 177: 109-113. 10.1016/j.psychres.2009.08.010.CrossRefPubMed Scharnholz B, Weber-Hamann B, Lederbogen F, Schilling C, Gilles M, Onken V, Frankhauser P, Kopf D, Deuschle M: Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial. Psychiatry Res. 2010, 177: 109-113. 10.1016/j.psychres.2009.08.010.CrossRefPubMed
Metadata
Title
A clinical study of the efficacy of a single session of individual exercise for depressive patients, assessed by the change in saliva free cortisol level
Authors
Megumi Ida
Itsurou Ida
Naoki Wada
Makoto Sohmiya
Masayuki Tazawa
Kenji Shirakura
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BioPsychoSocial Medicine / Issue 1/2013
Electronic ISSN: 1751-0759
DOI
https://doi.org/10.1186/1751-0759-7-18

Other articles of this Issue 1/2013

BioPsychoSocial Medicine 1/2013 Go to the issue